Open access peer-reviewed chapter

Infliximab Therapy for Plaque Psoriasis: The UCL Experience

By Pierre-Dominique Ghislain

Submitted: January 26th 2011Reviewed: November 8th 2011Published: February 15th 2012

DOI: 10.5772/25435

Downloaded: 1431

© 2012 The Author(s). Licensee IntechOpen. This chapter is distributed under the terms of the Creative Commons Attribution 3.0 License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

How to cite and reference

Link to this chapter Copy to clipboard

Cite this chapter Copy to clipboard

Pierre-Dominique Ghislain (February 15th 2012). Infliximab Therapy for Plaque Psoriasis: The UCL Experience, Psoriasis Jennifer Soung, IntechOpen, DOI: 10.5772/25435. Available from:

Embed this chapter on your site Copy to clipboard

<iframe src="http://www.intechopen.com/embed/psoriasis/infliximab-therapy-for-plaque-psoriasis-the-ucl-experience" />

Embed this code snippet in the HTML of your website to show this chapter

chapter statistics

1431total chapter downloads

More statistics for editors and authors

Login to your personal dashboard for more detailed statistics on your publications.

Access personal reporting

Related Content

This Book

Next chapter

Systemic Cyclosporin in the Treatment of Psoriasis

By Delia Colombo and Antonino Di Pietro

Related Book

First chapter

Skin Biopsy Procedures: How and Where to Perform a Proper Biopsy

By Z. Seia, L. Musso, Stefania Palazzini and M. Bertero

We are IntechOpen, the world's leading publisher of Open Access books. Built by scientists, for scientists. Our readership spans scientists, professors, researchers, librarians, and students, as well as business professionals. We share our knowledge and peer-reveiwed research papers with libraries, scientific and engineering societies, and also work with corporate R&D departments and government entities.

+3,550 Open Access Books

+57,400 Citations in Web of Science

+108,500 IntechOpen Authors and Academic Editors

+560,000 Unique visitors per month

More about us